// App-Quantinova.ai

1014 : The anti-Warburg agent BPM 31510 arbitrates fatty acid metabolism in eliciting an anticancer response

Researchers

Presenter

  • Bianca Jambhekar

Principal Investigators

  • Tulin Dadali

  • Anne R. Diers

  • Fei Gao

  • Hannah Rockwell

  • Emily Chen

  • Stephane Gesta

  • Vivek K. Vishnudas

  • Michael A. Kiebish

  • Niven R. Narain

  • Rangaprasad Sarangarajan

Medical Centers

  • Berg LLC, Framingham, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Triglyceride Level

Drug/Treatment

  • Trimetazidine

  • Carnitine

  • Metformin Hydrochloride

  • Ubidecarenone

  • Palmitic acid

  • Etomoxir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved